THORN RUN PARTNERS

Lobbying for SECRETOME THERAPEUTICS · Biotechnology company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $30,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Education related to neonatal stem cell research.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem